In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 51 for your search:
Drug:  thiotepa
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 59
Sponsor: Other
Protocol IDs: M09TNM, 2009-015238-31, NCT01057069

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12154, NCT01438112

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 6 months to less than 18 years
Sponsor: Other
Protocol IDs: ALL SCTped FORUM 2012, NCT01949129

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 10 and under
Sponsor: NCI, Other
Protocol IDs: ARET0321, NCI-2009-00421, COG-ARET0321, CDR0000573987, U10CA098543, NCT00554788

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: N12OLG, 2012-000838-19, NCT01646034

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 3 to 50
Sponsor: Other
Protocol IDs: MYS-07-HMO-CTIL, NCT00984412

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 54
Sponsor: Other
Protocol IDs: BELEHAPLO-1412001, NCT01220544

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 5 and under
Sponsor: Other
Protocol IDs: 2012-004842-14, 2012/1908, NCT02025881

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: SCT 0813 Haplo, NCT02053545

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 22
Sponsor: Other
Protocol IDs: AAAK8060, NCT02061800

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 10 to 69
Sponsor: Other
Protocol IDs: 2006LS032, UMN-MT2005-21, UMN-0608M90586, UMN-2006LS032, NCT00432094

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: GELTAMO-Z-RIC-Allo, EuDRACT nº:2007-003302-10, NCT00644371

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ZNS-00465, NCT00647049

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 08-087, NCT00739141

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 60
Sponsor: Other
Protocol IDs: 2008-0363, NCI-2012-01630, NCT00857389

16.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 14 to 55
Sponsor: NCI, Other
Protocol IDs: FHCRC-2222.00, P30CA015704, P01CA018029, IR-6907, CDR0000644201, 0903004832, NCT00914940

17.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 07CC12, REC - 07/H0808/193, EudraCT - 2007-001657-26, NCT00916045

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 5 to 19
Sponsor: Other
Protocol IDs: PNET HR+ 5, CSET 1329, NCT00936156

19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: EudraCT 2007-006016-33, NCT00961142

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 65
Sponsor: Other
Protocol IDs: 2009-0266, NCI-2011-03144, NCT01010217

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 26
Sponsor: Other
Protocol IDs: L 10,321, NYMC 525, NCT01049854

22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 75
Sponsor: Other
Protocol IDs: 10-050, NCT01119066

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: NHL-ZNS-Rezidiv, NCT01148173

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: IELSG32, NCT01011920

25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: BUS2009/1, NCT01025778
1    
New Search